Kevin Flaherty, MD

Scientific Advisory Board

Dr. Kevin Flaherty joins APIE-Therapeutics as a member of the Scientific Advisory Board.  He is currently the Director of the Michigan Medicine Interstitial Lung Disease program, Vice-Chair of the Medical School Institutional Review Board for Human Subjects Research, Associate Program Director of the Internal Medicine Residency Program, Co-Director of the University of Michigan Medical School Scientific Discovery Pathway, and the Steering committee Chair for the pulmonary fibrosis foundations Care Center Network and Patient Registry.  His clinical and research interests center around the diagnosis, monitoring, and care of patients with interstitial lung diseases.  He is an active participant on grants and clinical trials related to the study and treatment of patients with idiopathic interstitial pneumonias, particularly idiopathic pulmonary fibrosis.  


Dr. Kevin Flaherty holds an MD from Indiana University School of Medicine.

© 2020 by Apie Therapeutics. 

  • LinkedIn